EU Industrial Biotech Policy Priorities for SMEs
Join the EuropaBio Industrial Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the Green […]
Join the EuropaBio Industrial Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the Green […]
Join the EuropaBio Healthcare Biotechnology Team for a dive into EU policies that impact your current operations and will shape your future strategies. With the ongoing […]
Advanced Therapy Medicinal Products (ATMPs) in Europe On May 31st, from 11h to 12h30 CET, EuropaBio - the European Association for Bioindustries, will host the first […]
EuropaBio – the European Association for Bioindustries is delighted to invite you to its first public SME BioForum event - “SME BioForum 2022 – the voice […]
Rare Disease Day takes place on February 28th across the globe to raise awareness among policymakers and the public about rare diseases and their impact on patient's lives and their families...
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it can meet the challenges of the 21st century. The revision will redefine the regulatory framework for medicines and have a significant impact on the global innovation ecosystem.
Event agenda 12:00: Registration opens 12:30: Panel starts 13:45: Panel close and networking lunch 15:00: Close Confirmed Speakers Tomislav Sokol MEPMember SANT Committee, European Parliament Hilde […]